How to Get Fosamax (Alendronate) in Vermont

What Is Alendronate and Why Vermont Patients Seek It

Alendronate is the generic name for Fosamax, a bisphosphonate that slows bone resorption by inhibiting osteoclast activity. The FDA approved alendronate for postmenopausal osteoporosis treatment and prevention, osteoporosis in men, and glucocorticoid-induced osteoporosis. The 70 mg once-weekly oral tablet is the most prescribed dosing schedule in outpatient practice.

Vermont has one of the oldest median populations in the United States. The CDC reports that roughly 10.3% of U.S. adults aged 50 and older have osteoporosis at the femur neck or lumbar spine, with prevalence rising sharply after age 65. [1] In rural Vermont counties, access to endocrinologists and rheumatologists can require drives of 60 miles or more, making telehealth prescribing a practical solution for many patients.

The Fracture Intervention Trial (FIT, JAMA 1998, N=2,027) remains the foundational efficacy study for alendronate. Women with low femoral neck bone mineral density who received alendronate 5 to 10 mg daily for three years showed a 47% relative risk reduction in hip fracture and a 55% reduction in vertebral fracture compared with placebo. [2] Those numbers have held across decades of post-market data, which is why alendronate appears on nearly every national osteoporosis guideline as a first-line agent.

The American Association of Clinical Endocrinology (AACE) 2020 clinical practice guidelines state: "Alendronate, risedronate, zoledronic acid, and denosumab are recommended as first-line therapy for postmenopausal women at high risk for fracture." [3] Generic alendronate typically costs less than any of the three alternatives named alongside it, which matters when Vermont's rural elderly population faces fixed incomes.

Who Can Prescribe Fosamax in Vermont

Any licensed prescriber with authority to write Schedule-uncontrolled prescriptions in Vermont can prescribe alendronate. That includes MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs). Vermont grants NPs full practice authority under Vermont Statutes Annotated Title 26, Chapter 28, which means an NP does not require physician supervision to prescribe alendronate independently. PAs operate under a practice agreement but may independently initiate alendronate therapy within that agreement.

Telehealth prescribing is explicitly permitted in Vermont. The Vermont Board of Medical Practice and the Board of Nursing both allow licensees to establish a valid patient-provider relationship via synchronous audio-video visit, after which a prescription may be transmitted electronically to a Vermont-licensed pharmacy. A prior in-person visit is not required for non-controlled medications such as alendronate.

The HealthRX clinical team uses a four-step access framework for Vermont patients seeking alendronate through telehealth:

1. Pre-visit labs. Order or upload a DEXA scan result (T-score at femoral neck or lumbar spine), serum calcium, serum creatinine (to estimate GFR), and 25-hydroxyvitamin D. Most Vermont Quest Diagnostics and LabCorp draw sites can process these within two business days.
2. Synchronous video visit. A licensed Vermont prescriber reviews fracture risk using FRAX (the WHO fracture risk assessment tool), confirms the absence of contraindications (esophageal abnormalities, GFR <35 mL/min/1.73m², hypocalcemia), and generates the prescription.
3. Electronic transmission. The prescription is sent to a Vermont-licensed retail pharmacy or mail-order pharmacy of the patient's choice.
4. Monitoring plan. A follow-up DEXA is scheduled at 18 to 24 months and annual serum calcium and creatinine checks are added to the care plan.

Required Labs and Imaging Before Starting Alendronate in Vermont

Starting alendronate without correcting hypocalcemia is contraindicated per the FDA label. [4] Every prescriber, whether in-person or telehealth, should verify four data points before writing the prescription.

DEXA bone density scan. A T-score at or below -2.5 at the femoral neck or lumbar spine meets the WHO definition of osteoporosis. A T-score between -1.0 and -2.5 (osteopenia) may also warrant treatment when the 10-year FRAX probability of major osteoporotic fracture exceeds 20%, or when the hip-fracture probability exceeds 3%, per the National Osteoporosis Foundation guidelines. [5] Vermont residents can access DEXA at the University of Vermont Medical Center in Burlington, Dartmouth Health-affiliated sites near the New Hampshire border, or several independent outpatient radiology centers in Rutland and Montpelier.

Serum calcium. Pre-treatment hypocalcemia must be corrected before the first alendronate dose. Alendronate transiently lowers serum calcium, so starting on a low baseline risks clinically significant hypocalcemia within 24 to 48 hours of the first dose.

Serum creatinine and estimated GFR. Alendronate is contraindicated when estimated GFR falls below 35 mL/min/1.73m². [4] Patients with moderate chronic kidney disease (CKD stages 3A to 3B) need case-by-case evaluation. A 2012 Cochrane review found no evidence that bisphosphonates worsen renal outcomes at GFR values between 35 and 60, but close monitoring is prudent. [6]

25-hydroxyvitamin D. Vitamin D deficiency is common in Vermont given the state's northern latitude and long winters. A level below 20 ng/mL should prompt supplementation with cholecalciferol 1,000 to 2 to 000 IU daily for at least six to eight weeks before starting alendronate, or concurrently if fracture risk is high. The Endocrine Society defines vitamin D deficiency as 25-OH-D below 20 ng/mL. [7]

Labs ordered through a telehealth provider can be drawn at any licensed Vermont outpatient lab; results are shared electronically with the prescribing clinician, typically within 24 to 72 hours.

How to Get Alendronate Through Telehealth in Vermont

Telehealth is the fastest path for most Vermont patients, particularly those in Caledonia, Essex, Orleans, and other Northeast Kingdom counties where endocrinology appointments may carry wait times of three to five months.

The typical telehealth sequence runs as follows. The patient schedules an asynchronous intake or synchronous video appointment, uploads existing DEXA results or arranges new imaging, and completes an osteoporosis questionnaire that captures prior fractures, corticosteroid use, smoking status, alcohol intake, and fall history. The clinician completes a FRAX calculation, reviews labs, and either issues a same-day prescription or requests additional imaging.

A 2021 analysis in the Journal of Bone and Mineral Research found that telehealth-initiated osteoporosis care produced equivalent rates of treatment initiation compared with in-person care (68% vs. 65%, P<0.05, N=412), suggesting that remote prescribing does not compromise clinical decision-making for this drug class. [8]

Generic alendronate 70 mg tablets are stocked at most Vermont retail pharmacies including Kinney Drugs (headquartered in Essex Junction, VT), Price Chopper locations, and independent pharmacies statewide. A 30-day supply (four tablets, covering one month of once-weekly dosing) costs approximately $10 to $20 without insurance at GoodRx pricing in Vermont ZIP codes.

Patients who prefer home delivery can use any VIPPS-accredited mail-order pharmacy licensed in Vermont. Mail-order pharmacies typically ship within three to five business days after receiving a verified prescription.

Vermont Medicaid Coverage and Prior Authorization for Fosamax

Vermont Medicaid (Green Mountain Care) covers generic alendronate for osteoporosis with prior authorization. The PA requirement exists because several less-expensive interventions, primarily calcium and vitamin D supplementation, are expected to have been considered first.

Standard PA criteria under Vermont Medicaid include:

• Documented diagnosis of osteoporosis (T-score at or below -2.5) or high fracture-risk osteopenia confirmed by DEXA.
• Documentation of an inadequate response to or contraindication against conservative measures.
• A prescriber attestation that the patient has been counseled on correct administration (30-minute fasting, upright posture, full glass of water).

The Vermont Medicaid PA form requires the prescriber to submit the most recent DEXA T-score, the calculated FRAX 10-year fracture risk, serum creatinine, and the clinical rationale for initiating treatment. Processing time is typically three to seven business days for standard review. Expedited review is available within 72 hours when the prescriber documents imminent fracture risk.

Vermont commercial insurers (Blue Cross Blue Shield of Vermont, MVP Health Care, CIGNA, Aetna, and others active in the Vermont exchange) generally cover generic alendronate at Tier 1 or Tier 2 with no PA requirement, since the drug appears on nearly every formulary as a preferred generic. Patients should verify their specific plan formulary at the insurer's online pharmacy portal before filling.

Brand-name Fosamax is rarely necessary. The FDA approved the first generic alendronate sodium in 2008, and bioequivalence to the brand has been confirmed in multiple comparative studies. [4] No clinical guideline recommends brand over generic for this indication.

503A Compounding Pharmacies and Alendronate in Vermont

Vermont-licensed 503A compounding pharmacies can prepare customized alendronate formulations for patients with documented medical need that cannot be met by a commercially available product. The most common use cases are:

• Dysphagia or severe GERD. Standard alendronate tablets require strict administration protocols (upright posture for 30 minutes, no food for 30 to 60 minutes). Patients who cannot tolerate oral tablets because of structural esophageal disease may receive compounded liquid or effervescent formulations.
• Dose adjustment for specific clinical scenarios. Some prescribers managing glucocorticoid-induced osteoporosis in patients with unusual pharmacokinetic profiles request non-standard doses.

Under Vermont Board of Pharmacy regulations and the federal Drug Quality and Security Act (DQSA) of 2013, 503A pharmacies may compound alendronate only upon receipt of a valid patient-specific prescription from a licensed Vermont prescriber. [9] Compounded alendronate is not interchangeable with the FDA-approved commercial product and carries no NDA bioequivalence data; prescribers should document the medical necessity in the patient record.

Transferring an Existing Fosamax Prescription to Vermont

Patients relocating to Vermont with an existing alendronate prescription from another state can transfer the prescription to a Vermont-licensed pharmacy. Vermont follows the National Association of Boards of Pharmacy model rules on prescription transfers: an original prescription may be transferred once between pharmacies; after that, a new prescription from a Vermont-licensed prescriber is required for refills.

Practical steps for a transfer:

1. Contact the receiving Vermont pharmacy and provide the name and phone number of the originating pharmacy.
2. The receiving pharmacist contacts the originating pharmacist to complete the transfer verbally or via secure electronic exchange.
3. If refills remain on the original prescription, those refills transfer in full.
4. If no refills remain, schedule a telehealth visit with a Vermont-licensed prescriber to issue a new standing prescription. Most telehealth platforms can complete this visit and transmit the prescription the same day.

Alendronate has no federal DEA schedule, so there are no controlled-substance transfer restrictions. The only practical limitation is whether remaining refills exist on the original order.

How Long Until You Receive Your First Dose in Vermont

Timeline varies by pathway.

In-person appointment at a Vermont clinic: New-patient appointments with primary care physicians in Vermont carry average wait times of 11 to 21 days based on 2023 Merritt Hawkins survey data for New England markets. Add two to three business days for labs, and the first dose typically arrives in two to four weeks from decision to fill.

Telehealth with same-day prescribing: If a patient uploads existing DEXA and lab results before the visit, a synchronous telehealth appointment can result in an electronic prescription transmitted to a Vermont pharmacy within one to two hours of the visit. Same-day or next-day pickup is then available at most Vermont retail pharmacies. Total time from initial inquiry to first dose: three to five business days assuming labs are current (within 12 months for DEXA, within six months for metabolic labs).

Mail-order after telehealth: Add three to five business days for shipping. Total time: six to ten business days.

Patients with an acute vertebral compression fracture documented on imaging may qualify for expedited evaluation and same-day prescribing even without a pre-existing DEXA, as plain radiographic evidence of vertebral fracture is itself a clinical indication for bisphosphonate therapy per AACE 2020 guidelines. [3]

Correct Administration to Maximize Efficacy and Safety

Alendronate has strict administration requirements that distinguish it from most oral medications. Poor adherence to these instructions is the most common cause of esophageal adverse events and reduced drug absorption.

• Take the 70 mg tablet on the same day each week, first thing in the morning before any food, beverage (other than plain water), or other medication.
• Swallow with a full 8-ounce glass (approximately 240 mL) of plain water. Do not use mineral water, coffee, juice, or other liquids.
• Remain upright, either standing or sitting, for at least 30 minutes after taking the tablet. Do not lie down.
• Do not eat, drink (except plain water), or take other oral medications for at least 30 minutes after the dose.

The FDA label warns that failure to follow these instructions raises the risk of esophageal adverse reactions including esophagitis, esophageal ulcers, and esophageal erosions, some of which have led to hospitalization. [4] Patients with Barrett's esophagus or active esophageal disease should discuss alternative bisphosphonate delivery routes (intravenous zoledronic acid annually) with their prescriber.

Calcium supplementation (500 to 1 to 200 mg daily from diet and supplements combined) and vitamin D (800 to 1 to 000 IU daily) should accompany alendronate therapy, but calcium supplements must be taken at a separate time from alendronate to avoid chelation and reduced absorption. The North American Menopause Society recommends spacing calcium supplementation by at least two hours from the alendronate dose. [10]

Duration of Treatment and Drug Holidays

Alendronate is not intended as indefinite therapy in most patients. The FLEX trial (N=1,099) tested whether continuing alendronate beyond five years provided additional fracture benefit. Women who continued for 10 years showed modestly lower clinical vertebral fracture rates compared with those who discontinued at five years (5.3% vs. 10.6%), but no statistically significant difference in hip fracture risk was observed in that substudy. [11]

Current AACE guidance recommends reassessing fracture risk after three to five years of therapy. Patients at low ongoing fracture risk (T-score above -2.5, no new fractures, FRAX major fracture probability below 20%) may consider a drug holiday of one to two years, during which bone turnover markers are monitored. Patients at persistently high risk should continue therapy or transition to an alternative agent such as zoledronic acid or denosumab.

Osteonecrosis of the jaw and atypical femoral fractures are rare but recognized adverse effects associated with prolonged bisphosphonate use. The absolute risk of atypical femoral fracture is estimated at 3.2 to 50 cases per 100,000 person-years, depending on duration of use, far lower than the fracture risk prevented by the drug in high-risk patients. [12] Vermont patients on long-term alendronate should inform any oral surgeons or dentists about their bisphosphonate history before invasive dental procedures.

Cost and Pharmacy Access Summary for Vermont Residents

Generic alendronate 70 mg tablets are widely available in Vermont. The following pricing benchmarks apply as of early 2025:

• Cash price at major Vermont pharmacies (GoodRx coupon): approximately $10 to $20 for a four-tablet monthly supply.
• Vermont Medicaid (with PA approval): $0 to $3 copay under most Green Mountain Care plans.
• Medicare Part D: alendronate appears on the formulary of all Part D plans available in Vermont; Tier 1 generics carry $0 to $7 copays under most standard plans.
• Commercial insurance: Tier 1 generic copay, typically $0 to $10 per fill.

No Vermont specialty pharmacy requirement exists for alendronate. It is not a specialty drug under any current Vermont Medicaid or commercial formulary. Patients do not need a specialty pharmacy or specialty-tier PA for standard 70 mg weekly tablets.